Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Mechanisms of Action: Physiological Effects

Capnocytophaga ochracea: Characterization of a Plasmid-Encoded Extended-Spectrum TEM-17 β-Lactamase in the Phylum Flavobacter-Bacteroides

Agnes Rosenau, Blandine Cattier, Nathalie Gousset, Patrick Harriau, Alain Philippon, Roland Quentin
Agnes Rosenau
Département de Microbiologie Médicale et Moléculaire, Centre Hospitalier Universitaire Bretonneau, 37044 Tours cedex, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Blandine Cattier
Département de Microbiologie Médicale et Moléculaire, Centre Hospitalier Universitaire Bretonneau, 37044 Tours cedex, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nathalie Gousset
Département de Microbiologie Médicale et Moléculaire, Centre Hospitalier Universitaire Bretonneau, 37044 Tours cedex, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick Harriau
Département de Microbiologie Médicale et Moléculaire, Centre Hospitalier Universitaire Bretonneau, 37044 Tours cedex, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alain Philippon
Service de Bactériologie, Hôpital Cochin (Université Paris V), 75679 Paris cedex 14, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roland Quentin
Département de Microbiologie Médicale et Moléculaire, Centre Hospitalier Universitaire Bretonneau, 37044 Tours cedex, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/AAC.44.3.760-762.2000
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

A plasmid-encoded extended-spectrum TEM β-lactamase with a pI of 5.5 was detected in a Capnocytophaga ochracea clinical isolate. The bla gene was associated with a strong TEM-2 promoter and was derived from blaTEM-1a with a single-amino-acid substitution: Glu104→Lys, previously assigned to TEM-17, which is thus the first TEM β-lactamase to be reported in the phylum Flavobacter-Bacteroides.

The dissemination of antibiotic resistance is a clear example of gene exchange between distantly related bacteria (13). However, this phenomenon is rare enough that the presence of a TEM β-lactamase in Capnocytophaga ochracea, a Cytophagale belonging to the phylumFlavobacter-Bacteroides (14), is of note, this type of enzyme being previously described only in the very phylogenetically distant Proteobacteria (4, 17, 22). C. ochracea is a capnophilic gram-negative fusiform rod with gliding motility. It is part of the normal gingival flora in humans and causes gingivitis and periodontitis. It may cause systemic infections in immunocompromised and neutropenic patients (11). Antibiotic treatment was originally based on its susceptibility to penicillins, including benzylpenicillin (7). The organism was later shown to be susceptible to extended-spectrum cephalosporins, making it possible to prescribe these drugs (2). Enzymatic resistance to β-lactams, including extended-spectrum cephalosporins, was reported as early as 1986 in clinical isolates of C. ochracea (3, 8, 18, 19). The genetic basis of resistance was not determined for any of the resistant strains. We report for the first time a plasmid-encoded TEM extended-spectrum β-lactamase in a clinical isolate of C. ochracea.

(This work was presented at the 98th General Meeting of the American Society for Microbiology, Atlanta, Ga., 17 to 21 May 1998.)

C. ochracea CIP 105321 was isolated in 1996 at Bretonneau Hospital Tours, France, from a culture of blood from an 11-year-old child with acute myeloid leukemia, fever (39°C), severe neutropenia, and oral mucositis who had received an empiric antibiotic treatment, including ceftazidime. The β-lactamase reaction in the nitrocefin-disk test (Cefinase; bioMérieux, Marcy l'Etoile, France) was positive. The disk-agar diffusion test performed on chocolate agar containing 1% PolyVitex (bioMérieux) showed that strain CIP 105321 was resistant to penams (amoxicillin, ticarcillin, and piperacillin) and cephems (cephalothin, cefoperazone, cefuroxime, cefotaxime, ceftazidime, ceftriaxone, cefpirome, and cefepime), but susceptible to cefoxitin, aztreonam, piperacillin-tazobactam, and imipenem. There was extensive synergy between amoxicillin-clavulanic acid and β-lactam disks, including those for all extended-spectrum cephalosporins tested. The strain was also resistant to gentamicin, polymyxin B, and cotrimoxazole, as commonly reported in the genus Capnocytophaga(7, 19). MICs were determined by agar dilution on Wilkins-Chalgren agar (Difco, Detroit, Mich.) with an inoculum of 104 CFU per spot (3, 18). The MICs of the two β-lactamase inhibitors, clavulanic acid and sulbactam, were found to be 0.6 and 0.8 μg/ml, respectively. To prevent an intrinsic antibacterial effect of clavulanate and sulbactam, a concentration of 0.1 μg/ml (if combined with a β-lactam) was then used for all plates. The strain was resistant to amoxicillin (MIC, 512 μg/ml), had intermediate resistance to piperacillin (MIC, 32 μg/ml), and was more resistant to ceftazidime (MIC, 64 μg/ml) than to cefpirome, cefepime, and cefotaxime (MIC, 16 μg/ml). It was susceptible to imipenem and cefoxitin, as was the β-lactamase-negative control strain, CIP 103448. Clavulanic acid and sulbactam partly restored the activity of amoxicillin, cefotaxime, and ceftazidime (Table1).

View this table:
  • View inline
  • View popup
Table 1.

In vitro susceptibility of C. ochracea strains to antibiotics

Three types of crude β-lactamase extract were prepared. Lysis by sonication and by Triton treatment was performed as previously described (8). For lysis by both sonication and detergent, 4% Triton X-100 was added to the sonicated cells. The β-lactamase activity of the supernatants was estimated by the iodine procedure in gels containing benzylpenicillin, by comparing the decolorized zones obtained with that for a sonicated extract containing TEM-1 β-lactamase (6). β-Lactamase activity was not detected in a 24-h broth culture or a Triton extract. Weak activity was detected in a sonicated extract, and strong activity was obtained if Triton was added after sonication. The analytical isoelectric focusing method used was adapted from that described by Foweraker et al. (8), with polyacrylamide gels containing ampholines (Pharmacia, Uppsala, Sweden) with a pH range of 3.5 to 9.5. Focusing of the enzyme could only be achieved for extracts containing Triton and if 4% Triton was included in the gel. This was previously reported to be the case for two other β-lactamases in Capnocytophaga, possibly due to enzyme binding to membrane components (8, 18). The β-lactamase migrated as a single band with an estimated pI of 5.5 in comparisons with known β-lactamases (TEM-1, pI 5.4; TEM-3, pI 6.3; and TEM-4, pI 5.9).

Plasmid DNA isolated by alkaline lysis was about 9 kb in size. Plasmid curing was done by culture with ethidium bromide and replica plating (6). The cured clones were highly susceptible to all β-lactams tested (Table 1) and did not produce β-lactamase detectable by the nitrocefin test on colonies. Resistance to other antimicrobial agents was not affected.

PCR was performed with plasmid DNA as the template and a pair of primers (Eurogentec, Seraing, Belgium), 1079 [5′-d(GGTCTGACAGTTACCAATGC)-3′] and 6 [5′-d(GAAGACGAAAGGGCCTCGTG)-3′], internal toblaTEM-1, with nucleotide positions given according to the numbering of Sutcliffe (21). Both strands of the PCR product were sequenced by automated fluorescent sequencing with an ABI Prism 377 sequencer (Perkin-Elmer), by using Thermo Sequenase dye terminator cycle sequencing premixed version 2.0 (Amersham, Les Ulis, France). Analysis of the nucleotide sequence (Table2) showed that the gene encodingC. ochracea β-lactamase differed from theblaTEM-1a gene by four silent mutations (positions 469, 682, 863, and 985) and that there was a Glu104→Lys amino acid substitution in the protein according to the numbering scheme of Ambler et al. (1, 9). Lys104 substitution is common in extended-spectrum β-lactamases derived from TEM-1 or TEM-2 enzymes and is always associated with one to three additional amino acid changes at positions 21, 153, 164, 182, 237, 238, 240, and 265 (15;http://www.lahey.org/studies/webt.htm). The presence of single mutation Glu104→Lys has already been suspected on the basis of colony hybridization with specific oligonucleotide probes (oligotyping) in a single strain of Klebsiella pneumoniae. The enzyme was called TEM-17 (12). After sequencing of the corresponding gene, the deduced amino acid sequence was identical to that of TEM-15, and the enzyme was therefore redesignated TEM-15 (10). Because the β-lactamase of C. ochraceaCIP 105321 presents the single Glu104→Lys amino acid substitution, we assigned it the number TEM-17 (http://www.lahey.org/studies/webt.htm). As for most of these enzymes, the blaTEM-17 gene was associated with a strong TEM-2 promoter with a C-to-T substitution at nucleotide 32 that increases the amount of enzyme (5).

View this table:
  • View inline
  • View popup
Table 2.

Nucleotide and amino acid differences between blaTEM-1a, blaTEM-2, and blaTEM-17

It is not clear how Capnocytophaga acquired ablaTEM gene. Given the probable emergence in 1986 of the first isolates of Capnocytophaga producing extended-spectrum β-lactamases and the small size of the plasmids involved, the donating strain probably transferred the extended-spectrum β-lactamase gene via a transposon. However,Capnocytophaga may have acquired theblaTEM-1 gene via a transposon or small plasmid and then modified the blaTEM-1 gene by point mutation to give blaTEM-17, possibly due to selection pressure exerted by the extended-spectrum cephalosporins used to treat neutropenic patients. The ecological niche ofCapnocytophaga and the small size of the plasmid involved suggest that the donating strain was of the genusHaemophilus or Neisseria, in which TEM extended-spectrum β-lactamases have never been reported. The TEM-1 β-lactamase should therefore also be present inCapnocytophaga strains.

In conclusion, the emergence of such inactivating enzymes in theFlavobacter-Bacteroides phylum at the same time as in the very distant Proteobacteria phylum (16, 20) requires further molecular investigation to trace the movements of theblaTEM gene.

Nucleotide sequence accession number.The nucleotide sequence of blaTEM-17 has been assigned accession no.Y14574 in the EMBL Nucleotide Sequence Database.

ACKNOWLEDGMENTS

We thank M. Kiredjian, Laboratoire des Identifications Bactériennes, Institut Pasteur Paris, France, for the identification at the species level of the Capnocytophagastrain.

FOOTNOTES

    • Received 9 June 1999.
    • Returned for modification 2 September 1999.
    • Accepted 29 November 1999.
  • Copyright © 2000 American Society for Microbiology

REFERENCES

  1. 1.↵
    1. Ambler R. P.,
    2. Coulson A. F. W.,
    3. Frère J. M.,
    4. Ghuysen J. M.,
    5. Joris B.,
    6. Forsman M.,
    7. Levesque R. C.,
    8. Tiraby G.,
    9. Waley S. G.
    A standard numbering scheme for the class A β-lactamases. Biochem. J. 276 1991 269 272
    OpenUrlFREE Full Text
  2. 2.↵
    1. Arlet G.,
    2. Sanson-Le Pors M. J.,
    3. Casin I. M.,
    4. Ortenberg M.,
    5. Perol Y.
    In vitro susceptibility of 96 Capnocytophaga strains, including a β-lactamase producer, to new β-lactam antibiotics and six quinolones. Antimicrob. Agents Chemother. 31 1987 1283 1284
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Arlet G.,
    2. Sanson-Le Pors M. J.,
    3. Castaigne S.,
    4. Perol Y.
    Isolation of a strain of β-lactamase-producing Capnocytophaga ochracea. J. Infect. Dis. 155 1987 1346
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Bush K.,
    2. Jacoby G. A.,
    3. Medeiros A. A.
    A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39 1995 1211 1233
    OpenUrlFREE Full Text
  5. 5.↵
    1. Chen S.-T.,
    2. Clowes R. C.
    Variations between the nucleotide sequences of Tn1, Tn2, and Tn3 and expression of β-lactamase in Pseudomonas aeruginosa and Escherichia coli. J. Bacteriol. 169 1987 913 916
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Courvalin P.,
    2. Goldstein F.,
    3. Philippon A.,
    4. Sirot J.
    L'antibiogramme. 1985 MPC-Vidéom Paris, France
  7. 7.↵
    1. Forlenza S. W.,
    2. Newman M. G.,
    3. Horikoshi A. L.,
    4. Blachman U.
    Antimicrobial susceptibility of Capnocytophaga. Antimicrob. Agents Chemother. 19 1981 144 146
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Foweraker J. E.,
    2. Hawkey P. M.,
    3. Heritage J.,
    4. Van Landuyt H. W.
    Novel β-lactamase from Capnocytophaga sp. Antimicrob. Agents Chemother. 34 1990 1501 1504
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Goussard S.,
    2. Courvalin P.
    Sequence of the genes blaT-1B and blaT-2. Gene 102 1991 71 73
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    1. Goussard S.,
    2. Courvalin P.
    Updated sequence information for TEM β-lactamase genes. Antimicrob. Agents Chemother. 43 1999 367 370
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Kristensen B.,
    2. Schønheyder H. C.,
    3. Peterslund N. A.,
    4. Rosthøj S.,
    5. Clausen N.,
    6. Frederiksen W.
    Capnocytophaga (Capnocytophaga ochracea group) bacteremia in hematological patients with profound granulocytopenia. Scand. J. Infect. Dis. 27 1995 153 155
    OpenUrlPubMedWeb of Science
  12. 12.↵
    1. Mabilat C.,
    2. Courvalin P.
    Development of “oligotyping” for characterization and molecular epidemiology of TEM β-lactamases in members of the family Enterobacteriaceae. Antimicrob. Agents Chemother. 34 1990 2210 2216
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Maiden M. C. J.
    Horizontal genetic exchange, evolution, and spread of antibiotic resistance in bacteria. Clin. Infect. Dis. 27 1998 S12 S20
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Nakagawa Y.,
    2. Yamasato K.
    Emendation of the genus Cytophaga and transfer of Cytophaga agarovorans and Cytophaga salmonicolor to Marinilabilia gen. nov.: phylogenetic analysis of the Flavobacterium-Cytophaga complex. Int. J. Syst. Bacteriol. 46 1996 599 603
    OpenUrlCrossRef
  15. 15.↵
    1. Palzkill T.,
    2. Botstein D.
    Identification of amino acid substitutions that alter the substrate specificity of TEM-1 β-lactamase. J. Bacteriol. 174 1992 5237 5243
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Paul G. C.,
    2. Gerbaud G.,
    3. Bure A.,
    4. Philippon A. M.,
    5. Pangon B.,
    6. Courvalin P.
    TEM-4, a new plasmid-mediated β-lactamase that hydrolyzes broad-spectrum cephalosporins in a clinical isolate of Escherichia coli. Antimicrob. Agents Chemother. 33 1989 1958 1963
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. Philippon A.,
    2. Ben Redjeb S.,
    3. Fournier G.,
    4. Ben Hassen A.
    Epidemiology of extended spectrum β-lactamases. Infection 17 1989 347 354
    OpenUrlCrossRefPubMedWeb of Science
  18. 18.↵
    1. Roscoe D. L.,
    2. Zemcov S. J. V.,
    3. Thornber D.,
    4. Wise R.,
    5. Clarke A. M.
    Antimicrobial susceptibilities and β-lactamase characterization of Capnocytophaga species. Antimicrob. Agents Chemother. 36 1992 2197 2200
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    1. Rummens J. L.,
    2. Gordts B.,
    3. Van Landuyt H. W.
    In vitro susceptibility of Capnocytophaga species to 29 antimicrobial agents. Antimicrob. Agents Chemother. 30 1986 739 742
    OpenUrlAbstract/FREE Full Text
  20. 20.↵
    1. Sirot D.,
    2. Sirot J.,
    3. Labia R.,
    4. Morand A.,
    5. Courvalin P.,
    6. Darfeuille-Michaud A.,
    7. Perroux R.,
    8. Cluzel R.
    Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel β-lactamase. J. Antimicrob. Chemother. 20 1987 323 334
    OpenUrlCrossRefPubMedWeb of Science
  21. 21.↵
    1. Sutcliffe J. G.
    Nucleotide sequence of the ampicillin resistance gene of Escherichia coli plasmid pBR322. Proc. Natl. Acad. Sci. USA 75 1978 3737 3741
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    1. Woese C. R.
    Bacterial evolution. Microbiol. Rev. 51 1987 221 271
    OpenUrlFREE Full Text
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
Capnocytophaga ochracea: Characterization of a Plasmid-Encoded Extended-Spectrum TEM-17 β-Lactamase in the Phylum Flavobacter-Bacteroides
Agnes Rosenau, Blandine Cattier, Nathalie Gousset, Patrick Harriau, Alain Philippon, Roland Quentin
Antimicrobial Agents and Chemotherapy Mar 2000, 44 (3) 760-762; DOI: 10.1128/AAC.44.3.760-762.2000

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Capnocytophaga ochracea: Characterization of a Plasmid-Encoded Extended-Spectrum TEM-17 β-Lactamase in the Phylum Flavobacter-Bacteroides
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Capnocytophaga ochracea: Characterization of a Plasmid-Encoded Extended-Spectrum TEM-17 β-Lactamase in the Phylum Flavobacter-Bacteroides
Agnes Rosenau, Blandine Cattier, Nathalie Gousset, Patrick Harriau, Alain Philippon, Roland Quentin
Antimicrobial Agents and Chemotherapy Mar 2000, 44 (3) 760-762; DOI: 10.1128/AAC.44.3.760-762.2000
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Capnocytophaga
Gram-negative bacterial infections
plasmids
beta-lactamases

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596